Literature DB >> 8850395

Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients.

H M Oudemans-van Straaten1, P G Jansen, F J Hoek, S J van Deventer, A Sturk, C P Stoutenbeek, G N Tytgat, C R Wildevuur, L Eysman.   

Abstract

OBJECTIVES: To determine whether intestinal permeability increases during cardiac operations, and whether the degree of endotoxemia is related to this increase. Furthermore, to determine whether intestinal permeability is related to the hemodynamic state during operation and to postoperative systemic responses.
DESIGN: Prospective study.
SETTING: University hospital. PARTICIPANTS: Twenty-three male patients undergoing elective coronary artery bypass surgery.
INTERVENTIONS: Before surgery and during the fifth postoperative day, 100 mL of a solution containing L-rhamnose and cellobiose were administered orally.
MEASUREMENTS AND MAIN RESULTS: Intestinal permeability was assessed by measuring the urinary excretion of L-rhamnose and cellobiose. Endotoxin concentrations in blood and prime fluid, hemodynamics, oxygen consumption, gas exchange, fluid balance, and the dose of vasoactive drugs were measured. Systemic responses were assessed by measuring hypermetabolism, circulatory support, and gas exchange. Intestinal permeation of cellobiose, reflecting paracellular transport, significantly increased during operation (p < 0.01), and correlated with the amount of circulating endotoxin (r2 = 0.46; p < 0.01). A high dose of ephedrine administered during operation, low baseline central venous pressure, and a less positive fluid balance during operation were associated with high intestinal permeability (r2 = 0.7; p < 0.01). Intestinal permeability was related to postoperative systemic responses (r2 = 0.49; p < 0.01).
CONCLUSIONS: This study shows that during elective coronary artery bypass operations intestinal permeability between cells may increase. The degree of endotoxemia is related to this increase. Increased intestinal permeability is related to the use of ephedrine, especially during hypovolemia, and to postoperative systemic responses. Although a causative relation is not shown, these results might indicate that hypovolemia and vasoconstriction should be avoided during the operation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8850395     DOI: 10.1016/s1053-0770(96)80235-7

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  17 in total

1.  Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patients.

Authors:  Mitchell P Fink
Journal:  Intensive Care Med       Date:  2002-01-12       Impact factor: 17.440

Review 2.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels.

Authors:  M P Fink; T W Evans
Journal:  Intensive Care Med       Date:  2002-02-08       Impact factor: 17.440

3.  Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Christin Heinrich; Jochen Renner; Jochen Cremer; Markus Steinfath; Jens Scholz; Martin Albrecht
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

4.  Acute acalculous cholecystitis following coronary artery bypass surgery.

Authors:  D G Healy; D Veerasingam; P R O'Connell; J Hurley
Journal:  Ir J Med Sci       Date:  2004 Jul-Sep       Impact factor: 1.568

5.  Retractile mesenteritis presenting as protein-losing gastroenteropathy.

Authors:  Bahe Rajendran; Donald R Duerksen
Journal:  Can J Gastroenterol       Date:  2006-12       Impact factor: 3.522

Review 6.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

7.  Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock.

Authors:  Runkuan Yang; Tomoyuki Harada; Kevin P Mollen; Jose M Prince; Ryan M Levy; Joshua A Englert; Margot Gallowitsch-Puerta; LiHong Yang; Huan Yang; Kevin J Tracey; Brian G Harbrecht; Timothy R Billiar; Mitchell P Fink
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

8.  Effects of cardiopulmonary bypass on tight junction protein expressions in intestinal mucosa of rats.

Authors:  Ying-Jie Sun; Wei-Min Chen; Tie-Zheng Zhang; Hui-Juan Cao; Jin Zhou
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

9.  Determinants of gastrointestinal complications in cardiac surgery.

Authors:  Giuseppe D'Ancona; Richard Baillot; Brigitte Poirier; Francois Dagenais; José Ignacio Saez de Ibarra; Richard Bauset; Patrick Mathieu; Daniel Doyle
Journal:  Tex Heart Inst J       Date:  2003

10.  Gastric hypercarbia and adverse outcome after cardiac surgery.

Authors:  Minoo N Kavarana; Robert J Frumento; Andrew L Hirsch; Mehmet C Oz; Daniel C Lee; Elliott Bennett-Guerrero
Journal:  Intensive Care Med       Date:  2003-04-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.